Başar Sırmagül
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
Papers in
-
- Phenothiazines and Benzothiazines Synthesis and Activities 2
-
- Synthesis and Biological Evaluation 3
- Synthesis and Reactivity of Heterocycles 2
- Co-authors
- Kevser Erol (14 shared papers)Ebru Başaran (2 shared papers)Yasemin Yazan (2 shared papers)Müzeyyen Demirel (2 shared papers)Sinem Ilgın (6 shared papers)Fatma Sultan Kılıç (6 shared papers)Engin Yıldırım (4 shared papers)Garip Şahin (3 shared papers)
- Journals
- Human & Experimental Toxicology (2 papers)Clinical and Experimental Hypertension (2 papers)Renal Failure (1 paper)Journal of Biomedical Nanotechnology (1 paper)Cardiovascular Toxicology (1 paper)
- Partner nations
- TürkiyeUnited StatesSwitzerland
In The Last Decade
Başar Sırmagül
37 papers receiving 416 citations
Peers
Comparison fields: 5 of 81
- Pharmaceutical Science 95
- Nephrology 27
- Pharmacology 27
- Pathology and Forensic Medicine 48
- Biochemistry 18
Countries citing papers authored by Başar Sırmagül
This map shows the geographic impact of Başar Sırmagül's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Başar Sırmagül with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Başar Sırmagül more than expected).
Fields of papers citing papers by Başar Sırmagül
This network shows the impact of papers produced by Başar Sırmagül. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Başar Sırmagül. The network helps show where Başar Sırmagül may publish in the future.
Co-authors
The 25 scholars most cited alongside Başar Sırmagül, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 84 | |
| 2 | 2004 | 40 | |
| 3 | 2013 | 34 | |
| 4 | Antinociceptive effects of gabapentin & its mechanism of action in experimental animal studies. | 2012 | 31 |
| 5 | 2009 | 20 | |
| 6 | 2008 | 18 | |
| 7 | 2005 | 18 | |
| 8 | 2021 | 14 | |
| 9 | 2011 | 13 | |
| 10 | 2006 | 12 | |
| 11 | 2011 | 11 | |
| 12 | 2012 | 10 | |
| 13 | 2013 | 10 | |
| 14 | 2016 | 10 | |
| 15 | 2013 | 10 | |
| 16 | 2012 | 8 | |
| 17 | 2006 | 8 | |
| 18 | 2004 | 8 | |
| 19 | 2016 | 7 | |
| 20 | 2006 | 6 |
About Başar Sırmagül
Başar Sırmagül is a scholar working on Molecular Biology, Organic Chemistry, Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Physiology, having authored 37 papers that have together received 426 indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (5 papers), Pulmonary Hypertension Research and Treatments (4 papers), Vitamin D Research Studies (3 papers), Nitric Oxide and Endothelin Effects (3 papers), Synthesis and Biological Evaluation (3 papers), Phenothiazines and Benzothiazines Synthesis and Activities (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Synthesis and Reactivity of Heterocycles (2 papers). The work is most often cited by research in Pharmaceutical Science (95 citations), Nephrology (27 citations), Pharmacology (27 citations), Pathology and Forensic Medicine (48 citations) and Biochemistry (18 citations). Başar Sırmagül has collaborated with scholars based in Türkiye, United States and Switzerland. Frequent co-authors include Kevser Erol, Ebru Başaran, Yasemin Yazan, Müzeyyen Demirel, Sinem Ilgın, Fatma Sultan Kılıç, Engin Yıldırım, Garip Şahin, Ahmet Uğur Yalçın and Ahmet Çağrı Karaburun. Their work appears in journals such as Human & Experimental Toxicology, Clinical and Experimental Hypertension, Renal Failure, Journal of Biomedical Nanotechnology and Cardiovascular Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.